Related Experiment Video

Updated: Apr 11, 2026

Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration
07:46

Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration

Published on: June 18, 2018

12.8K

Age-Related Neurodegeneration Prevention Through mTOR Inhibition: Potential Mechanisms and Remaining Questions

Jordan B Jahrling, Remi-Martin Laberge1

  • 1Buck Institute for Research on Aging, 8001 Redwood Blvd. Novato, CA, USA. RLaberge@buckinstitute.org.

Current Topics in Medicinal Chemistry
|June 11, 2015
PubMed

Insights

Chronic mTOR inhibition, particularly with rapamycin, shows promise in delaying age-related neurodegenerative diseases like Alzheimer's and Parkinson's. Further research into mTOR pathway effectors may offer new therapeutic strategies.

Area of Science:

  • Neuroscience
  • Gerontology
  • Pharmacology

Background:

  • Global aging population drives increased prevalence of neurodegenerative diseases.
  • Rapamycin extends lifespan in model organisms, suggesting potential for age-related disease intervention.
  • Mammalian target of rapamycin (mTOR) pathway is implicated in aging and neurodegeneration.

Purpose of the Study:

  • Review evidence for mTOR inhibition, specifically rapamycin, in delaying neurodegeneration.
  • Discuss mechanisms of rapamycin's neuroprotective effects and cognitive restoration.
  • Evaluate rapamycin's side effects and explore alternative therapeutic strategies targeting mTOR downstream effectors.

Main Methods:

  • Literature review of studies on mTOR inhibition and neurodegeneration.
  • Analysis of rapamycin's mechanisms of action and potential side effects.
  • Exploration of small molecule alternatives and novel therapeutic targets (S6K1, S6K2).

Main Results:

  • Evidence supports mTOR inhibition as a valid strategy to delay age-related neurodegeneration.
  • Rapamycin may prevent neurodegeneration and restore cognitive function through various mechanisms.
  • Concerns regarding rapamycin's side effects may be overstated, supporting its clinical potential.

Conclusions:

  • mTOR inhibition represents a promising therapeutic avenue for age-related neurodegenerative diseases.
  • Targeting downstream effectors like S6K2 offers potential for developing novel, safer interventions.
  • Refined experimental models are needed to accurately assess intervention efficacy in neurodegeneration research.

More Related Videos

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

8.9K
Application of Passive Head Motion to Generate Defined Accelerations at the Heads of Rodents05:04

Application of Passive Head Motion to Generate Defined Accelerations at the Heads of Rodents

Published on: July 21, 2022

2.3K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.4K
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
21.5K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.7K